疫情防控中的有效抗病毒药物:过去的错误,未来的需求
Antonios-Periklis Panagiotopoulos1, Cleo Anastassopoulou1, Athanasios Tsakris1
1Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
概括
未来的流行病需要更快的反应. 提出一个专门的抗病毒研究和开发议程,以补充以疫苗为中心的战略,确保公平的获取和更好的成本效益分析,以确保全球卫生安全.
科学领域:
- 流行病的准备情况.
- 抗病毒研究的研究.
- 全球卫生安全全球卫生安全
背景情况:
- 目前的流行病应对系统在速度和灵活性方面面临限制.
- COVID-19 R&D 资金不成比例地支持疫苗而不是抗病毒药物.
- 关于抗病毒功效的早期数据有限或误导,阻碍了它们的使用.
研究的目的:
- 为未来的流行病准备提出专门的抗病毒议程.
- 解决以疫苗为中心的流行病战略中的治疗盲点.
- 确保全球平等地获得有效的抗病毒干预措施.
主要方法:
- 协调广泛的抗病毒药物的研发工作.
- 资助对高严重性病原体进行2/3期临床试验.
- 实现快速制造规模扩大和公平的全球准入战略.
主要成果:
- 抗病毒药物在早期疫情控制和特定人群中具有潜在的优势.
- 一个协调的抗病毒议程可以填补关键的治疗缺口.
- 拟议的战略旨在实现透明度,公平性和基于证据的严格决策.
结论:
- 专门的抗病毒议程对于提高疫情应对灵活性和有效性至关重要.
- 将抗病毒药物与疫苗相结合,提供了一个更全面的流行病准备战略.
- 未来的战略必须严格评估疫苗和抗病毒药物的成本效益和风险效益比率.
相关概念视频
The Antiviral System of Bacteria and Archaea: CRISPR
601
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
601
Steps in Outbreak Investigation
472
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
472
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920


